IS3878A - Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja - Google Patents
Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfjaInfo
- Publication number
- IS3878A IS3878A IS3878A IS3878A IS3878A IS 3878 A IS3878 A IS 3878A IS 3878 A IS3878 A IS 3878A IS 3878 A IS3878 A IS 3878A IS 3878 A IS3878 A IS 3878A
- Authority
- IS
- Iceland
- Prior art keywords
- imidazodiazepines
- drugs
- compounds
- preparation
- imidazodiazepines compounds
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- BMGXAZCDDYTVFV-UHFFFAOYSA-N imidazo[4,5-c]diazepine Chemical class C1=CN=NC2=NC=NC2=C1 BMGXAZCDDYTVFV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH179191 | 1991-06-17 | ||
| CH114092 | 1992-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS3878A true IS3878A (is) | 1992-12-18 |
Family
ID=25686778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS3878A IS3878A (is) | 1991-06-17 | 1992-06-12 | Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5387585A (en:Method) |
| EP (1) | EP0519307A3 (en:Method) |
| JP (1) | JPH078869B2 (en:Method) |
| KR (1) | KR930000517A (en:Method) |
| AU (1) | AU655472B2 (en:Method) |
| CA (1) | CA2069382A1 (en:Method) |
| CZ (1) | CZ185092A3 (en:Method) |
| FI (1) | FI922827A7 (en:Method) |
| HU (1) | HU9201929D0 (en:Method) |
| IE (1) | IE921945A1 (en:Method) |
| IL (1) | IL102175A0 (en:Method) |
| IS (1) | IS3878A (en:Method) |
| NO (1) | NO922367L (en:Method) |
| NZ (1) | NZ243091A (en:Method) |
| TW (1) | TW201311B (en:Method) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW349100B (en) * | 1994-11-11 | 1999-01-01 | Hoffmann La Roche | Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines |
| JPH10298078A (ja) * | 1997-05-06 | 1998-11-10 | Mitsubishi Chem Corp | 抗不安薬 |
| TWI239333B (en) * | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
| US6686352B2 (en) * | 2001-05-18 | 2004-02-03 | Hoffmann-La Roche Inc. | Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives |
| ES2441874T3 (es) * | 2001-06-12 | 2014-02-06 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos |
| AU2005293820B2 (en) | 2004-10-12 | 2010-11-25 | F. Hoffmann-La Roche Ag | Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders |
| WO2006045430A1 (en) * | 2004-10-20 | 2006-05-04 | F. Hoffmann-La Roche Ag | Imidazo-benzodiazepine derivatives |
| JP4751398B2 (ja) * | 2004-10-20 | 2011-08-17 | エフ．ホフマン−ラ ロシュ アーゲー | ハロゲン置換ベンゾジアゼピン誘導体 |
| WO2006063708A1 (en) * | 2004-12-14 | 2006-06-22 | F.Hoffmann-La Roche Ag | Tetracyclic imidazo-benzodiazepines as gaba receptors modulators |
| ATE477255T1 (de) * | 2005-10-11 | 2010-08-15 | Hoffmann La Roche | Imidazobenzdiazepinderivate |
| AU2009300357B2 (en) * | 2008-09-23 | 2014-07-03 | The Johns Hopkins University | Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| US9322831B2 (en) | 2008-09-23 | 2016-04-26 | The Johns Hopkins University | DDX3 as a biomarker for cancer and methods related thereto |
| AU2014240289B2 (en) * | 2008-09-23 | 2015-12-03 | The Johns Hopkins University | Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| EA027840B1 (ru) | 2010-11-15 | 2017-09-29 | Эйджинбайо, Инк. | Производные пиридазина, композиции и способы лечения когнитивного нарушения |
| RS57508B1 (sr) | 2013-09-06 | 2018-10-31 | Aurigene Discovery Tech Ltd | 1,2,4-derivati oksadiazola kao imunomodulatori |
| CN106068256B (zh) | 2013-12-20 | 2020-10-23 | 艾吉因生物股份有限公司 | 用于治疗认知损害的苯并二氮杂*衍生物、组合物和方法 |
| CN114213356A (zh) | 2015-03-10 | 2022-03-22 | 奥瑞基尼探索技术有限公司 | 作为免疫调节剂的1,2,4-噁二唑和噻二唑化合物 |
| SG11201706902SA (en) * | 2015-03-10 | 2017-09-28 | Aurigene Discovery Tech Ltd | 3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators |
| CN108026107B (zh) | 2015-06-19 | 2021-07-30 | 艾吉因生物股份有限公司 | 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法 |
| AU2016378723B2 (en) | 2015-12-22 | 2021-09-30 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
| BR112019012821A2 (pt) | 2016-12-19 | 2019-11-26 | Agenebio Inc | derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo |
| US20180170941A1 (en) * | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| IL310023B1 (en) | 2017-06-21 | 2025-08-01 | SHY Therapeutics LLC | Compounds interacting with the RAS superfamily for the treatment of cancer, inflammation, RAS pathologies and fibrotic diseases |
| WO2019061324A1 (en) | 2017-09-29 | 2019-04-04 | Curis Inc. | CRYSTALLINE FORMS OF IMMUNOMODULATORS |
| EP3694841A1 (en) | 2017-10-11 | 2020-08-19 | Aurigene Discovery Technologies Limited | Crystalline forms of 3-substituted 1,2,4-oxadiazole |
| EA202090746A1 (ru) | 2017-11-03 | 2020-08-17 | Ориджен Дискавери Текнолоджис Лимитед | Двойные ингибиторы путей tim-3 и pd-1 |
| KR20200084333A (ko) | 2017-11-06 | 2020-07-10 | 오리진 디스커버리 테크놀로지스 리미티드 | 면역조절을 위한 병행 요법 |
| CA3104478A1 (en) | 2018-06-19 | 2019-12-26 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| EP3898609A1 (en) | 2018-12-19 | 2021-10-27 | Shy Therapeutics LLC | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1143728A (en) * | 1979-10-04 | 1983-03-29 | Max Gerecke | Imidazodiazepine derivatives |
| DE3587913D1 (de) * | 1984-01-19 | 1994-10-06 | Hoffmann La Roche | Imidazodiazepin-Derivate. |
| US4897392A (en) * | 1989-07-03 | 1990-01-30 | Hoechst-Roussel Pharmaceuticals, Inc. | 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines |
| DK443589D0 (da) * | 1989-09-08 | 1989-09-08 | Ferrosan As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| DK41191D0 (da) * | 1991-03-07 | 1991-03-07 | Novo Nordisk As | Heterocycliske forbindelser, deres fremstilling og anvendelse |
-
1992
- 1992-05-15 TW TW081103807A patent/TW201311B/zh active
- 1992-05-25 CA CA002069382A patent/CA2069382A1/en not_active Abandoned
- 1992-06-10 NZ NZ243091A patent/NZ243091A/en unknown
- 1992-06-10 EP EP19920109745 patent/EP0519307A3/de not_active Withdrawn
- 1992-06-10 HU HU9201929A patent/HU9201929D0/hu unknown
- 1992-06-11 IL IL102175A patent/IL102175A0/xx unknown
- 1992-06-12 JP JP4179406A patent/JPH078869B2/ja not_active Expired - Lifetime
- 1992-06-12 AU AU18234/92A patent/AU655472B2/en not_active Ceased
- 1992-06-12 IS IS3878A patent/IS3878A/is unknown
- 1992-06-16 KR KR1019920010394A patent/KR930000517A/ko not_active Withdrawn
- 1992-06-16 CZ CS921850A patent/CZ185092A3/cs unknown
- 1992-06-16 NO NO92922367A patent/NO922367L/no unknown
- 1992-06-17 FI FI922827A patent/FI922827A7/fi not_active Application Discontinuation
- 1992-07-01 IE IE194592A patent/IE921945A1/en not_active Application Discontinuation
-
1993
- 1993-11-15 US US08/153,234 patent/US5387585A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0519307A2 (de) | 1992-12-23 |
| NO922367L (no) | 1992-12-18 |
| JPH05202051A (ja) | 1993-08-10 |
| EP0519307A3 (en) | 1993-04-21 |
| KR930000517A (ko) | 1993-01-15 |
| NO922367D0 (no) | 1992-06-16 |
| CA2069382A1 (en) | 1992-12-18 |
| JPH078869B2 (ja) | 1995-02-01 |
| FI922827A7 (fi) | 1992-12-18 |
| AU1823492A (en) | 1992-12-24 |
| IL102175A0 (en) | 1993-01-14 |
| NZ243091A (en) | 1994-11-25 |
| IE921945A1 (en) | 1992-12-30 |
| TW201311B (en:Method) | 1993-03-01 |
| AU655472B2 (en) | 1994-12-22 |
| US5387585A (en) | 1995-02-07 |
| CZ185092A3 (en) | 1993-12-15 |
| HU9201929D0 (en) | 1992-08-28 |
| FI922827A0 (fi) | 1992-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS3878A (is) | Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja | |
| FI923775A7 (fi) | 2-piperatsinoniyhdisteet, niiden valmistus ja käyttö | |
| FI955248A7 (fi) | 1-Bifenyylimetyyli-imitdatsolin johdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| DK0515312T3 (da) | Farmaceutisk præparat | |
| FI941378L (fi) | Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus | |
| ITMI920528A0 (it) | 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico | |
| NO921958L (no) | Farmasoeytisk preparat | |
| HUT71740A (en) | 2-fluoroalkyl-substituted benzimidazoles, their preparation and their use as insecticides | |
| FI940889A7 (fi) | Uudet isatsiinioksiimijohdannaiset, niiden valmistus ja käyttö | |
| FI925501A7 (fi) | Imidatsoliyhdisteitä, niiden valmistus ja käyttö | |
| FI970997L (fi) | Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö | |
| FI922982A7 (fi) | 2-aminopyrimidiini-4-karboksamidijohdannaisia, niiden valmistus ja niiden terapeuttinen käyttö | |
| FI934680A7 (fi) | Aryylimorfoliini, valmistus ja käyttö | |
| GB9123353D0 (en) | New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same | |
| FI930716A7 (fi) | Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö | |
| FI914526A7 (fi) | Yhdiste, sen valmistus ja käyttö | |
| FI921814A7 (fi) | 2-aminopyrimidiini-4-karboksiamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| FI920663A7 (fi) | Polyhydroksisyklopentaanin johdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| FI914525A7 (fi) | Yhdiste, käyttö ja valmistus | |
| FI950533L (fi) | Seco-nukleosidien liponulkeotidit, niiden valmistaminen sekä niiden käyttö virusten vastaisina lääkkeinä | |
| IL97366A0 (en) | Aryl-propyl-amines,their preparation and their use as fungicides | |
| FI922980A7 (fi) | 2-piperidinyylipyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| NO942228D0 (no) | Ipsapiron-legemiddeltilberedning | |
| FI922981A7 (fi) | 2-aminopyrimidiini-4-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| GB9206062D0 (en) | Heterocyclic compounds,their preparation and pharmaceutical use |